Myovant Sciences Ltd. Uncategorized Contracts & Agreements

17 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Letter Agreement by and between Myovant Sciences GmbH and Pfizer, Inc. dated September 19, 2022
Myovant Sciences Ltd.
Biotechnology
2022
Amendment No.1 to Myovant Sciences Ltd. 2020 Inducement Plan
Myovant Sciences Ltd.
Biotechnology
2022
Letter Agreement, dated July 27, 2021, by and between Myovant Sciences GmbH and Pfizer, Inc
Myovant Sciences Ltd.
Biotechnology
NY
2021
Letter Agreement
Myovant Sciences Ltd.
Biotechnology
NY
2021
Commitment Letter Amendment Letter, dated December 22, 2020, by and between Sumitomo Dainippon Pharma Co., Ltd. and the Registrant
Myovant Sciences Ltd.
Biotechnology
2021
Form of Option Grant Notice and Option Agreement under 2020 Inducement Plan
Myovant Sciences Ltd.
Biotechnology
2020
2020 Inducement Plan
Myovant Sciences Ltd.
Biotechnology
NY
2020
Commitment Letter Amendment Letter
Myovant Sciences Ltd.
Biotechnology
2020
Commitment Letter, dated August 5, 2020, by and between Sumitomo Dainippon Pharma Co., Ltd. and the Registrant
Myovant Sciences Ltd.
Biotechnology
NY
2020
Description of Common Shares
Myovant Sciences Ltd.
Biotechnology
2020
Letter Agreement, dated October 31, 2019, by and between the Registrant and Sumitomo Dainippon Pharma Co., Ltd
Myovant Sciences Ltd.
Biotechnology
2020
LICENSEAGREEMENT by and between TAKEDA PHARMACEUTICALS INTERNATIONAL AG and ROIVANT ENDOCRINOLOGY LTD. Dated as of April 29, 2016
Myovant Sciences Ltd.
Biotechnology
NY
2016
RIGHT OF FIRST NEGOTIATION AND BOARDOBSERVER AGREEMENT
Myovant Sciences Ltd.
Biotechnology
NY
2016
LICENSEAGREEMENT by and between TAKEDA PHARMACEUTICALS INTERNATIONAL AG and ROIVANT ENDOCRINOLOGY LTD. Dated as of April 29, 2016
Myovant Sciences Ltd.
Biotechnology
NY
2016
Myovant Sciences,Inc. 2000 Sierra Point Parkway, Suite 550, Brisbane, CA 94005 myovant.com
Myovant Sciences Ltd.
Biotechnology
2016
OPTION AGREEMENT
Myovant Sciences Ltd.
Biotechnology
NY
2016
LICENSEAGREEMENT by and between TAKEDA PHARMACEUTICALS INTERNATIONAL AG and ROIVANT ENDOCRINOLOGY LTD. Dated as of April 29, 2016
Myovant Sciences Ltd.
Biotechnology
NY
2016